| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19845255
[patent_doc_number] => 20250090606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => COMPOSITIONS FOR TREATMENT OF A FATTY LIVER OR FIBROTIC LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/727324
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18727324
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/727324 | COMPOSITIONS FOR TREATMENT OF A FATTY LIVER OR FIBROTIC LIVER DISEASE | Jan 12, 2023 | Pending |
Array
(
[id] => 18404440
[patent_doc_number] => 20230165790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => NASAL FOAM VIA CRIBRIFORM PLATE FOR MEDICATION DELIVERY TO THE BRAIN AND/OR BODY AND FOR NASAL MOISTURIZATION AND HYGIENE
[patent_app_type] => utility
[patent_app_number] => 18/153320
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153320 | NASAL FOAM VIA CRIBRIFORM PLATE FOR MEDICATION DELIVERY TO THE BRAIN AND/OR BODY AND FOR NASAL MOISTURIZATION AND HYGIENE | Jan 10, 2023 | Abandoned |
Array
(
[id] => 18391145
[patent_doc_number] => 20230159363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => COMPOSITION WITH A TIME RELEASE MATERIAL FOR REMOVING HALOGENATED HYDROCARBONS FROM CONTAMINATED ENVIRONMENTS
[patent_app_type] => utility
[patent_app_number] => 18/094883
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094883
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094883 | Composition with a time release material for removing halogenated hydrocarbons from contaminated environments | Jan 8, 2023 | Issued |
Array
(
[id] => 18374405
[patent_doc_number] => 20230149484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTIC AND PREBIOTIC TO TREAT STUNTING
[patent_app_type] => utility
[patent_app_number] => 18/147948
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147948
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147948 | PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF PROBIOTIC AND PREBIOTIC TO TREAT STUNTING | Dec 28, 2022 | Pending |
Array
(
[id] => 18628456
[patent_doc_number] => 20230287320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => CELL CULTURE SUBSTRATE, CANCER CELL AGGREGATE AND METHOD FOR MANUFACTURING SAME USING SAID SUBSTRATE, AND DRUG SCREENING METHOD USING SAID CANCER CELL AGGREGATE
[patent_app_type] => utility
[patent_app_number] => 18/147939
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147939
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147939 | CELL CULTURE SUBSTRATE, CANCER CELL AGGREGATE AND METHOD FOR MANUFACTURING SAME USING SAID SUBSTRATE, AND DRUG SCREENING METHOD USING SAID CANCER CELL AGGREGATE | Dec 28, 2022 | Pending |
Array
(
[id] => 18339681
[patent_doc_number] => 20230131630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHOD OF SCREENING FOR A SUBSTANCE THAT ACTS ON A CELL MASS
[patent_app_type] => utility
[patent_app_number] => 18/146108
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146108 | Method of screening for a substance that acts on a cell mass | Dec 22, 2022 | Issued |
Array
(
[id] => 18531100
[patent_doc_number] => 20230236171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHODS, CULTURE MEDIAS AND DEVICES FOR GENERATING EMBRYOS IN VITRO FROM STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/065480
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065480
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065480 | Methods, culture medias and devices for generating embryos in vitro from stem cells | Dec 12, 2022 | Issued |
Array
(
[id] => 18675550
[patent_doc_number] => 20230313158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => SOLUBLE ENPP1 PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/063263
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063263
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063263 | SOLUBLE ENPP1 PROTEINS AND USES THEREOF | Dec 7, 2022 | Pending |
Array
(
[id] => 19709584
[patent_doc_number] => 20250019726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => A PROCESS TO TREAT A CARBON DIOXIDE COMPRISING GAS
[patent_app_type] => utility
[patent_app_number] => 18/712073
[patent_app_country] => US
[patent_app_date] => 2022-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18712073
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/712073 | A PROCESS TO TREAT A CARBON DIOXIDE COMPRISING GAS | Nov 23, 2022 | Pending |
Array
(
[id] => 18239252
[patent_doc_number] => 20230071563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BOTULINUM TOXIN
[patent_app_type] => utility
[patent_app_number] => 17/987626
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17987626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/987626 | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BOTULINUM TOXIN | Nov 14, 2022 | Pending |
Array
(
[id] => 18339191
[patent_doc_number] => 20230131140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => HUMAN ORIGIN PROBIOTIC LACTOBACILIUS RHAMNOSUS HL-200 TO REDUCE LEAKY GUT BY METABOLIZING ETHANOLAMINE
[patent_app_type] => utility
[patent_app_number] => 17/973909
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17973909
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/973909 | Human origin probiotic lactobacillus rhamnosus HL-200 to reduce leaky gut by metabolizing ethanolamine | Oct 25, 2022 | Issued |
Array
(
[id] => 18180462
[patent_doc_number] => 20230041191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => METHODS AND SYSTEMS FOR IN-VITRO MILK PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 17/971686
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971686 | METHODS AND SYSTEMS FOR IN-VITRO MILK PRODUCTION | Oct 23, 2022 | Abandoned |
Array
(
[id] => 18708141
[patent_doc_number] => 20230330726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => METHOD FOR TARGETED REGULATION OF SOIL MICROBES TO SYNCHRONIZE HEAVY METAL/METALLOID TRANSFORMATION AND GREENHOUSE GAS EMISSION REDUCTION AND USE
[patent_app_type] => utility
[patent_app_number] => 17/961276
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/961276 | Method for targeted regulation of soil microbes to synchronize heavy metal/metalloid transformation and greenhouse gas emission reduction and use | Oct 5, 2022 | Issued |
Array
(
[id] => 19241046
[patent_doc_number] => 12011462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cells
[patent_app_type] => utility
[patent_app_number] => 17/934460
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13616
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934460 | Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cells | Sep 21, 2022 | Issued |
Array
(
[id] => 18265318
[patent_doc_number] => 20230086560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => Nerve Guidance Conduit Comprising Neural Crest Stem-Like Cells and/or Schwann Cell Precursor-Like Cells and Methods of Making and Using the Same
[patent_app_type] => utility
[patent_app_number] => 17/950446
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/950446 | Nerve guidance conduit comprising neural crest stem-like cells and/or Schwann cell precursor-like cells and methods of making and using the same | Sep 21, 2022 | Issued |
Array
(
[id] => 19691267
[patent_doc_number] => 20250009812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => USE OF BACTEROIDES FRAGILIS IN PREVENTION AND TREATMENT OF CANCER-RELATED DIARRHEA
[patent_app_type] => utility
[patent_app_number] => 18/700420
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700420
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700420 | USE OF BACTEROIDES FRAGILIS IN PREVENTION AND TREATMENT OF CANCER-RELATED DIARRHEA | Sep 18, 2022 | Pending |
Array
(
[id] => 19658835
[patent_doc_number] => 20240425900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH
[patent_app_type] => utility
[patent_app_number] => 18/687075
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18687075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/687075 | METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH | Aug 29, 2022 | Pending |
Array
(
[id] => 18391665
[patent_doc_number] => 20230159883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHODS AND COMPOSITIONS FOR PRESERVING BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/822860
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822860 | Methods and compositions for preserving bacteria | Aug 28, 2022 | Issued |
Array
(
[id] => 19815110
[patent_doc_number] => 20250073317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/293972
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4903
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18293972
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/293972 | CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES | Aug 24, 2022 | Pending |
Array
(
[id] => 19075311
[patent_doc_number] => 11944654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Bacteriotherapy for clostridium difficile colitis
[patent_app_type] => utility
[patent_app_number] => 17/886274
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 12416
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886274
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/886274 | Bacteriotherapy for clostridium difficile colitis | Aug 10, 2022 | Issued |